Marina Yu. Buyanova

Marina Yu. Buyanova

Auto-generated profile, based on publicly available information

Marina Yu. Buyanova

Grove Biopharma Inc 1375 W. Fulton St., Ste. 650 Chicago 60558 IL USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2018 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
DPDehua Pei
Dehua Pei
MBMarina Buyanova
Marina Buyanova

1 May 2015 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
VDVolha Dzmitruk
Volha Dzmitruk
ASAleksandra Szulc
Aleksandra Szulc
DSDzmitry Shcharbin
Dzmitry Shcharbin
AJAnna Janaszewska
Anna Janaszewska
NSNatallia Shcharbina
Natallia Shcharbina
MBMaria Bryszewska
Maria Bryszewska

16 February 2024 in Advanced Materials
Verified
Journal Article
Open access
KCKendal P. Carrow
Kendal P. Carrow
HHHaylee L. Hamilton
Haylee L. Hamilton
MHMadeline P. Hopps
Madeline P. Hopps
YLYang Li
Yang Li
BQBaofu Qiao
Baofu Qiao
NGNathan C. Gianneschi
Nathan C. Gianneschi
Successful and selective inhibition of the cytosolic protein‐protein interaction (PPI) between nuclear factor erythroid 2‐related factor 2 (Nrf2) and Kelch‐like ECH‐associating protein 1 (Keap1) can enhance the antioxidant response, with the potential for a therapeutic effect in a range of settings including in neurodegenerative disease (ND). Small molecule inhibitors have been developed, yet many have off‐target effects, or are otherwise limited by poor cellular permeability. Peptide‐based strategies have also been attempted to enhance specificity, yet face challenges due to susceptibility to degradation and lack of cellular penetration. Herein, these barriers are overcome utilizing a polymer‐based proteomimetics. The protein‐like polymer (PLP) consists of a synthetic, lipophilic polymer backbone displaying water soluble Keap1‐binding peptides on each monomer unit forming a brush polymer architecture. The PLPs are capable of engaging Keap1 and displacing the cellular protective transcription factor Nrf2, which then translocates to the nucleus, activating the antioxidant response element (ARE). PLPs exhibit increased Keap1 binding affinity by several orders of magnitude compared to free peptides, maintain serum stability, are cell‐penetrant, and selectively activate the ARE pathway in cells, including in primary cortical neuronal cultures. Keap1/Nrf2‐inhibitory PLPs have the potential to impact the treatment of disease states associated with dysregulation of oxidative stress, such as NDs.

22 August 2017 in Organic & Biomolecular Chemistry
Verified
Journal Article
Open access
PDF file
CGCarlos E. Gutierrez-Ulloa
Carlos E. Gutierrez-Ulloa
MBMarina Yu. Buyanova
Marina Yu. Buyanova
Evgeny ApartsinEvgeny Apartsin
Evgeny Apartsin
AVAlya G. Venyaminova
Alya G. Venyaminova
FMF. Javier de la Mata
F. Javier de la Mata
RRRafael Gómez Ramírez
Rafael Gómez Ramírez
A novel family of amphiphilic ionic carbosilane dendrons with fatty acids at the focal point spontaneously self-assemble in aqueous solution into spherical micelles. Their potential use as nanocarriers for therapeutics have been demonstrated.

3 January 2014 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
Evgeny ApartsinEvgeny Apartsin
Evgeny Apartsin
MBMarina Yu. Buyanova
Marina Yu. Buyanova
DNDarya Novopashina
Darya Novopashina
ERElena Ryabchikova
Elena Ryabchikova
AFAnton V. Filatov
Anton V. Filatov
AVAlya G. Venyaminova
Alya G. Venyaminova

28 December 2017 in Chemnanomat
Verified
Journal Article
Closed access
PDF file
CGCarlos E. Gutierrez‐Ulloa
Carlos E. Gutierrez‐Ulloa
MBMarina Yu. Buyanova
Marina Yu. Buyanova
Evgeny ApartsinEvgeny Apartsin
Evgeny Apartsin
AVAlya G. Venyaminova
Alya G. Venyaminova
FMFrancisco Javier De La Mata
Francisco Javier De La Mata
RRRafael Gómez Ramírez
Rafael Gómez Ramírez